Rhythm Biosciences LimitedASX: RHY

2nd Generation, ColoSTAT Multiplex Alpha Kit Outperforms

· Issued by Rhythm Biosciences Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Rhythm Biosciences Limited has announced the performance evaluation results of its second-generation ColoSTAT® Multiplex Alpha Kit, which shows superior analytical results compared to the original kit. The preliminary testing involved patient serum samples and demonstrated a statistically significant classification of samples as either cancer or non-cancer. The company plans to work with its contract manufacturing organization to develop the Beta version of the assay for commercial validation.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Rhythm Biosciences Limited on 6ix

Earlier from Rhythm Biosciences

Later from Rhythm Biosciences

All Rhythm Biosciences news releases